March 02, 2009
GlaxoSmithKline PLC has agreed to pay $28 million to settle two proposed class actions over claims that the company's Puerto Rico plant produced defective versions of the company's antidepressant Paxil CR that caused the pills to split apart into their active ingredient and controlled release halves.